Frontiers in Immunology (Jul 2024)

Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study

  • Aleksandra Nowakowska,
  • Seung Mi Lee,
  • Minjee Kim,
  • Jungmin Chun,
  • Sehyun Kim,
  • Sehyun Kim,
  • Byung Chul Kim,
  • Hyun Ju In,
  • Eunji Lee,
  • Chanyeong Lee,
  • Hyeondong Lee,
  • Yuyeon Jang,
  • Hansam Cho,
  • Jinha Kim,
  • Jeesun Lee,
  • Hee-Jung Lee,
  • Yoo-Kyoung Lee,
  • Joong Shin Park,
  • Young Bong Kim,
  • Young Bong Kim

DOI
https://doi.org/10.3389/fimmu.2024.1359209
Journal volume & issue
Vol. 15

Abstract

Read online

IntroductionAlthough the safety and effectiveness of COVID-19 vaccination during pregnancy have been proven, there is still little data explaining neonatal outcomes of maternal pre-pregnancy vaccination.MethodsHere, we investigated the impact of vaccination and SARS-CoV-2 infection on maternal-neonate immune response in a cohort study involving 141 pregnant individuals, and defined the importance of maternal COVID-19 vaccination timing for its effectiveness.Results and discussionOur data indicate that vertically transferred maternal hybrid immunity provides significantly better antiviral protection for a neonate than either maternal post-infection or post-vaccination immunity alone. Higher neutralization potency among mothers immunized before pregnancy and their newborns highlights the promising role of pre-pregnancy vaccination in neonatal protection. A comparison of neutralizing antibody titers calculated for each dyad suggests that infection and pre-/during-pregnancy vaccination all support transplacental transfer, providing the offspring with strong passive immunity against SARS-CoV-2. Analysis of neutralizing antibody levels in maternal sera collected during pregnancy and later during delivery shows that immunization may exert a positive effect on maternal protection.

Keywords